X0206 3 2019-02-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001766329 Gross Paul Edward C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 0 1 0 0 See Remarks Common Stock 2345 D Stock Option (right to buy) 22.99 2026-01-25 Common Stock 60000 D Stock Option (right to buy) 68.31 2027-03-27 Common Stock 15000 D Stock Option (right to buy) 58.43 2028-03-01 Common Stock 9000 D Restricted Stock Units 2027-03-27 Common Stock 4219 D Restricted Stock Units 2028-03-01 Common Stock 9000 D The option vested as to 25% of the shares on January 25, 2017, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The option vested as to 25% of the shares on March 1, 2018, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The option vests as to 25% of the shares on March 1, 2019, and the remainder vests in substantially equal installments over the 36 months immediately following such date. The Restricted Stock Units vested as to 25% of the units on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Each Restricted Stock Unit represents the right to receive one share of Common Stock. The Restricted Stock Units vest as to 25% of the units on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Executive Vice President, General Counsel and Chief Compliance Officer /s/ Paul Gross 2019-02-01